[What can the clinician expect today from PSA determination?].
Since its characterization in 1979, PSA has become an indispensable tumoral marker to justify hospitalization of patients with prostate cancer. In addition to being a standard tumor marker used to follow the course of the disease, PSA can also be used as a therapeutic indicator of prostate cancer. PSA is becoming increasingly important for this latter application.
Teillac
P
P
Service d'Urologie, Hôpital Saint-Louis, Paris, France.
D014408:Biomarkers, Tumor / Q000032:analysis*; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011300:Preoperative Care; D017430:Prostate-Specific Antigen / Q000032:analysis*; D011470:Prostatic Hyperplasia / Q000175:diagnosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000276:immunology; D011933:Reagent Kits, Diagnostic
D014408:Biomarkers, Tumor; D011933:Reagent Kits, Diagnostic; D017430:Prostate-Specific Antigen